-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q9OlBYeJBoYplGn3Z142MCi5fyUuhdUCMGZ3FzT0M09UddH9iOksv2oKymP0IwEs KQq/guxfyFUQf983tNBwfw== 0001419041-10-000001.txt : 20100226 0001419041-10-000001.hdr.sgml : 20100226 20100226141310 ACCESSION NUMBER: 0001419041-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100226 DATE AS OF CHANGE: 20100226 EFFECTIVENESS DATE: 20100226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-111231 FILM NUMBER: 10638090 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 D 1 primary_doc.xml X0603 D LIVE 0001419041 Tocagen Inc 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400 DELAWARE None None Corporation true 2007 Harry Gruber 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Thomas Darcy 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Douglas Jolly 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Dennis Berman 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Pharmaceuticals Decline to Disclose 06 false 2010-01-27 false true false 0 3000001 3000001 0 Offer by the Issuer of up to 1,578,948 shares of Series C-1 Preferred Stock at $1.90 per share. false 2 0 0 0 false Tocagen Inc Thomas E. Darcy Thomas E. Darcy Chief Financial Officer 2010-02-19 -----END PRIVACY-ENHANCED MESSAGE-----